Antiphospholipid syndrome and pre-eclampsia

Seminars in Thrombosis and Hemostasis

Volumn 37, Issue 2, 2011, Pages 141-145

  Heilmann, Lothar ^a   Schorsch, Martin ^a   Hahn, Thomas ^a   Fareed, Jawed ^b  

^a Institute of Reproduction   (Germany)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Antiphospholipid syndrome (APS); obstetric APS; severe P EC; Sydney criteria

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT;

ANTIBODY DETECTION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; INCIDENCE; MAJOR CLINICAL STUDY; PREECLAMPSIA; PRIORITY JOURNAL;

ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; ASPIRIN; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS COAGULATION INHIBITOR; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY-SPECIFIC BETA 1-GLYCOPROTEINS; RISK;

EID: 79952293333     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0030-1270341     Document Type: Article

References (54)

1. Bick R L. Antiphospholipid thrombosis syndromes. Clin Appl Thromb Hemost 2001 7 4 241-258 (Pubitemid 32988886)
2. Brown M A., Lindheimer M D., de Swiet M, Van Assche A, Moutquin J M. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001 20 1 ix-xiv (Pubitemid 32672922)
3. Milne F, Redman C, Walker J et al. The pre-eclampsia community guideline (PRECOG): how to screen for and detect onset of pre-eclampsia in the community. BMJ 2005 330 7491 576-580 (Pubitemid 40380353)
4. Hiby S E., Walker J J., O'Shaughnessy K M. et al. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med 2004 200 8 957-965 (Pubitemid 39431121)
5. Sargent I L., Borzychowski A M., Redman C WG. NK cells and pre-eclampsia. J Reprod Immunol 2007 76 1-2 40-44 (Pubitemid 350100876)
6. Carp H JA. Antiphospholipid syndrome in pregnancy. Curr Opin Obstet Gynecol 2004 16 2 129-135 (Pubitemid 38519747)
7. Zhang J, Tian Z. UNK cells: their role in tissue re-modelling and preeclampsia. Semin Immunopathol 2007 29 2 123-133 (Pubitemid 47596392)
8. Carp H JA, Asherson R A., Shoenfeld Y. Intravenous immunoglobulin in pregnancies complicated by the antiphospholipid syndrome: what is its role? J Clin Rheumatol 2001 7 5 291-294 (Pubitemid 32977725)
9. Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ 2005 330 7491 565-571
10. Katano K, Aoki A, Sasa H, Ogasawara M, Matsuura E, Yagami Y. 2-Glycoprotein I-dependent anticardiolipin antibodies as a predictor of adverse pregnancy outcomes in healthy pregnant women. Hum Reprod 1996 11 3 509-512 (Pubitemid 26125247)
11. Nodler J, Moolamalla S R., Ledger E M., Nuwayhid B S., Mulla Z D. Elevated antiphospholipid antibody titers and adverse pregnancy outcomes: analysis of a population-based hospital dataset. BMC Pregnancy Childbirth 2009 9 11
12. van Pampus M G., Dekker G A., Wolf H et al. High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia. Am J Obstet Gynecol 1999 180 5 1146-1150 (Pubitemid 29259008)
13. Yamamoto T, Yoshimura S, Geshi Y et al. Measurement of antiphospholipid antibody by ELISA using purified 2-glycoprotein I in preeclampsia. Clin Exp Immunol 1993 94 1 196-200 (Pubitemid 23308388)
14. Yasuda M, Takakuwa K, Tokunaga A, Tanaka K. Prospective studies of the association between anticardiolipin antibody and outcome of pregnancy. Obstet Gynecol 1995 86 4 Pt 1 555-559
15. Clark E AS, Silver R M., Branch D W. Do antiphospholipid antibodies cause preeclampsia and HELLP syndrome? Curr Rheumatol Rep 2007 9 3 219-225 (Pubitemid 46954780)
16. Le Thi Thuong D, Tieulié N, Costedoat N et al. The HELLP syndrome in the antiphospholipid syndrome: retrospective study of 16 cases in 15 women. Ann Rheum Dis 2005 64 2 273-278 (Pubitemid 40193625)
17. George D, Vasanth L, Erkan D, Bass A, Salmon J, Lockshin M D. Primary antiphospholipid syndrome presenting as HELLP syndrome: a clinical pathology conference held by the Division of Rheumatology at Hospital for Special Surgery. HSS J 2007 3 2 216-221
18. Yamada H, Atsumi T, Kobashi G et al. Antiphospholipid antibodies increase the risk of pregnancy-induced hypertension and adverse pregnancy outcomes. J Reprod Immunol 2009 79 2 188-195
19. Zhang J, Zeisler J, Hatch M C., Berkowitz G. Epidemiology of pregnancy-induced hypertension. Epidemiol Rev 1997 19 2 218-232 (Pubitemid 28099772)
20. Branch D W., Khamashta M A. Antiphospholipid syndrome: obstetric diagnosis, management, and controversies. Obstet Gynecol 2003 101 6 1333-1344 (Pubitemid 36694363)
21. Caruso A, De Carolis S, Di Simone N. Antiphospholipid antibodies in obstetrics: new complexities and sites of action. Hum Reprod Update 1999 5 3 267-276 (Pubitemid 29271965)
22. Giannakopoulos B, Passam F, Rahgozar S, Krilis S A. Current concepts on the pathogenesis of the antiphospholipid syndrome. Blood 2007 109 2 422-430 (Pubitemid 46105935)
23. Girardi G, Mackman N. Tissue factor in antiphospholipid antibody-induced pregnancy loss: a pro-inflammatory molecule. Lupus 2008 17 10 931-936
24. Salmon J E., de Groot P G. Pathogenic role of antiphospholipid antibodies. Lupus 2008 17 5 405-411 (Pubitemid 351798717)
25. Bates S M., Greer I A., Hirsh J, Ginsberg J S. Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004 126 3, Suppl 627S-644S (Pubitemid 39297966)
26. Wilson W A., Gharavi A E., Koike T et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999 42 7 1309-1311 (Pubitemid 30265586)
27. Miyakis S, Lockshin M D., Atsumi T et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006 4 2 295-306
28. Kutteh W H. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 1996 174 5 1584-1589 (Pubitemid 26165282)
29. Rai R, Cohen H, Dave M, Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 1997 314 7076 253-257 (Pubitemid 27047378)
30. Derksen R HWM, Khamashta M A., Branch D W. Management of the obstetric antiphospholipid syndrome. Arthritis Rheum 2004 50 4 1028-1039 (Pubitemid 38480813)
31. Alarcón-Segovia D, Boffa M C., Branch W et al. Prophylaxis of the antiphospholipid syndrome: a consensus report. Lupus 2003 12 7 499-503 (Pubitemid 36890139)
32. Cowchock S. Treatment of antiphospholipid syndrome in pregnancy. Lupus 1998 7 Suppl 2 95-97
33. Huong D LT, Wechsler B, Bletry O, Vauthier-Brouzes D, Lefebvre G, Piette J-C. A study of 75 pregnancies in patients with antiphospholipid syndrome. J Rheumatol 2001 28 9 2025-2030 (Pubitemid 32803780)
34. Tincani A, Branch W, Levy R A. et al. Treatment of pregnant patients with antiphospholipid syndrome. Lupus 2003 12 7 524-529 (Pubitemid 36890144)
35. Kupferminc M J., Fait G, Many A et al. Low-molecular-weight heparin for the prevention of obstetric complications in women with thrombophilias. Hypertens Pregnancy 2001 20 1 35-44 (Pubitemid 32672926)
36. Kalk J J., Huisjes A J., de Groot C JM et al. Recurrence rate of pre-eclampsia in women with thrombophilia influenced by low-molecular-weight heparin treatment? Neth J Med 2004 62 3 83-87 (Pubitemid 39089465)
37. Brandt J T., Triplett D A., Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost 1995 74 4 1185-1190
38. Branch D W., Andres R, Digre K B., Rote N S., Scott J R. The association of antiphospholipid antibodies with severe preeclampsia. Obstet Gynecol 1989 73 4 541-545 (Pubitemid 19086960)
39. Dekker G A., de Vries J IP, Doelitzsch P M. et al. Underlying disorders associated with severe early-onset preeclampsia. Am J Obstet Gynecol 1995 173 4 1042-1048
40. Faden D, Tincani A, Tanzi P et al. Anti-beta 2 glycoprotein I antibodies in a general obstetric population: preliminary results on the prevalence and correlations with pregnancy outcome. Anti-beta2 glycoprotein I antibodies are associated with some obstetrical complications, mainly preeclampsia-eclampsia. Eur J Obstet Gynecol Reprod Biol 1997 73 37-42 (Pubitemid 27224458)
41. Mello G, Parretti E, Marozio L et al. Thrombophilia is significantly associated with severe preeclampsia: results of a large-scale, case-controlled study. Hypertension 2005 46 6 1270-1274 (Pubitemid 43189722)
42. Vashisht A, Regan L. Antiphospholipid syndrome in pregnancy-an update. J R Coll Physicians Edinb 2005 35 337-339
43. Branch D W. Antiphospholipid antibodies and reproductive outcome: the current state of affairs. J Reprod Immunol 1998 38 1 75-87 (Pubitemid 28221414)
44. Lim W L., Crowther M A., Eikelboom J W. Management of antiphospholipid antibody syndrome: a systematic review. JAMA 2006 295 9 1050-1057
45. Pattison N S., Chamley L W., McKay E J., Liggins G C., Butler W S. Antiphospholipid-antibodies in pregnancy: prevalence and clinical association. BJOG 1993 100 909-913 (Pubitemid 23308274)
46. Dreyfus M, Hedelin G, Kutnahorsky R et al. Antiphospholipid antibodies and preeclampsia: a case-control study. Obstet Gynecol 2001 97 1 29-34 (Pubitemid 32057151)
47. Branch D W., Porter T F., Rittenhouse L et al, National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Antiphospholipid antibodies in women at risk for preeclampsia. Am J Obstet Gynecol 2001 184 5 825-832; discussion 832-834
48. Sletnes K E., Wisløff F, Moe N, Dale P O. Antiphospholipid antibodies in pre-eclamptic women: relation to growth retardation and neonatal outcome. Acta Obstet Gynecol Scand 1992 71 2 112-117
49. Cervera R, Piette J C., Font J et al, Euro-Phospholipid Project Group. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 2002 46 1019-1027 (Pubitemid 34303815)
50. Lee R M., Brown M A., Branch D W., Ward K, Silver R M. Anticardiolipin and anti-2-glycoprotein-I antibodies in preeclampsia. Obstet Gynecol 2003 102 2 294-300
51. Lynch A, Marlar R, Murphy J et al. Antiphospholipid antibodies in predicting adverse pregnancy outcome. A prospective study. Ann Intern Med 1994 120 6 470-475 (Pubitemid 24075224)
52. Heilmann L, Schorch M, Hahn T et al. Pregnancy outcome in women with antiphospholipid antibodies: report on a retrospective study. Semin Thromb Hemost 2008 34 8 794-802
53. Topping J, Quenby S, Farquharson R, Malia R, Greaves M. Marked variation in antiphospholipid antibodies during pregnancy: relationships to pregnancy outcome. Hum Reprod 1999 14 1 224-228 (Pubitemid 29046343)
54. Devreese K, Hoylaerts M F. Laboratory diagnosis of the antiphospholipid syndrome: a plethora of obstacles to overcome. Eur J Haematol 2009 83 1 1-16